Journal of Cardiothoracic Surgery

FEBRUARY 9, 2024

Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-sur.

Congenital Heart Disease 52

Congenital Heart Disease Heart Transplant Transplant Congenital 52

Journal of the American Heart Association

DECEMBER 12, 2023

BackgroundScreening for cardiovascular disease is currently recommended before kidney transplantation. Outcomes were degree of coronary heart disease, revascularization rate following screening, major adverse cardiovascular events, and all‐cause death. 10.8]; and HR, 2.1 [95% 3.9]) and all‐cause death (HR, 12.0 [95%

Transplant 40

Transplant Heart Disease Cardiovascular Disease Outcomes 40

Circulation: Heart Failure

FEBRUARY 1, 2024

BACKGROUND:In 2018, an algorithm-based allocation system for heart transplantation (HT) was implemented in France. The cumulative incidence of waitlist mortality estimated with competing risk analysis and incidence of transplantation were compared between diagnosis groups. 2.58];P=0.94; congenital heart disease, 1.82 [95% CI, 0.78–4.26];P=0.17).

Heart Failure 40

Heart Failure Congenital Heart Disease Congenital Cardiomyopathy 40

Science Daily - Heart Disease

APRIL 26, 2024

Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. The highly positive outcomes observed in primate models highlight the potential of this strategy. However, the risk of arrhythmias following this procedure is reportedly high.

Transplant 106

Transplant Arrhythmia Research Outcomes 106

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 12, 2024

This study aimed to investigate the early and late efficacy, survival, and safety of CRT in patients with tetralogy of Fallot.METHODS:Data were analyzed from an observational, retrospective, multicenter cohort, initiated jointly by the Pediatric and Congenital Electrophysiology Society and the International Society of Adult Congenital Heart Disease.

Congenital Heart Disease 40

Congenital Heart Disease Outcomes Electrophysiology Congenital 40

DAIC

MARCH 6, 2024

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. 5 Kutty, S., et al (2016).

Pediatrics 105

Pediatrics Ultrasound Heart Transplant Echocardiogram 105

Cardiometabolic Health Congress

AUGUST 8, 2024

This blog post explores the development of such partnerships and their potential to transform healthcare outcomes. 4 Keys To Partnering With Patients: The Cornerstone of Effective Cardiorenal Metabolic Management At the heart of any successful healthcare intervention lies the patient.

Education 59

Education Kidney Disease Diabetes Cardiovascular Disease 59